🇺🇸 FDA
Patent

US 9522948

GP100-specific T cell receptors and related materials and methods of use

granted A61KA61K38/00A61P

Quick answer

US patent 9522948 (GP100-specific T cell receptors and related materials and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/00, A61P, A61P35/04